LICENSE AGREEMENTLicense Agreement • August 12th, 2015 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
THIS LICENSE AGREEMENT (this “Agreement”) dated as of August 11, 2015 (the “Effective Date”), is entered into between IMPRIMIS PHARMACEUTICALS, INC., a Delaware corporation (“Imprimis”), having a place of business at 12264 El Camino Real, Suite 350, San Diego, California 92130, U.S.A., on the one hand, and ADVANCED DOSAGE FORMS, INC., a Canadian corporation (“ADF”), having a place of business at 3700 St-Patrick, suite 240, Montreal, Quebec, H4E 1A2, Canada, and JOHN DIGENOVA, an individual (“DiGenova”, and together with ADF, collectively, the “ADF Parties”), on the other hand. The parties hereby agree as follows:
